Page last updated: 2024-11-13
paichongding
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
paichongding: a neonicotinoid insecticide; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 44571837 |
CHEMBL ID | 519270 |
SCHEMBL ID | 255346 |
MeSH ID | M0593816 |
Synonyms (9)
Synonym |
---|
paichongding |
CHEMBL519270 |
SCHEMBL255346 |
DTXSID9058498 |
948994-16-9 |
1-[(6-chloropyridin-3-yl)methyl]-7-methyl-8-nitro-5-propoxy-3,5,6,7-tetrahydro-2h-imidazo[1,2-a]pyridine |
1-((6-chloropyridin-3-yl)methyl)-7-methyl-8-nitro-5-propoxy-1,2,3,5,6,7-hexahydroimidazo[1,2-a]pyridine |
1-[(6-chloro-3-pyridinyl)methyl]-1,2,3,5,6,7-hexahydro-7-methyl-8-nitro-5-propoxyimidazo[1,2-a]pyridine; 1-[(6-chloropyridin-3-yl)-methyl]-5-propoxy-7-methyl-8-nitro-1,2,3,5,6,7-hexahydroimidazo[1,2-a]pyridine; 1-[(6-chloropyridin-3-yl)methyl]-7-methyl-8- |
1ST20545 |
Research Excerpts
Overview
Paichongding is an adicyclicnitromethylene neonicotinoid insecticide with a cis-configuration. It is currently marketed as racemate against sucking and biting insects.
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Bioassays (6)
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID1082710 | Insecticidal activity against adult Aphis craccivora (cowpea aphid) assessed as larvicidal activity at 500 mg/l after 24 hr | 2012 | Journal of agricultural and food chemistry, Jan-11, Volume: 60, Issue:1 | Design, synthesis, and particular biological behaviors of chain-opening nitromethylene neonicotinoids with cis configuration. |
AID1082709 | Insecticidal activity against adult Aphis craccivora (cowpea aphid) assessed as larvicidal activity after 24 hr | 2012 | Journal of agricultural and food chemistry, Jan-11, Volume: 60, Issue:1 | Design, synthesis, and particular biological behaviors of chain-opening nitromethylene neonicotinoids with cis configuration. |
AID371212 | Insecticidal activity against Aphis craccivora assessed as mortality at 500 mg/L | 2008 | Bioorganic & medicinal chemistry letters, Dec-15, Volume: 18, Issue:24 | cis-Nitromethylene neonicotinoids as new nicotinic family: synthesis, structural diversity, and insecticidal evaluation of hexahydroimidazo[1,2-alpha]pyridine. |
AID371213 | Insecticidal activity against Aphis craccivora | 2008 | Bioorganic & medicinal chemistry letters, Dec-15, Volume: 18, Issue:24 | cis-Nitromethylene neonicotinoids as new nicotinic family: synthesis, structural diversity, and insecticidal evaluation of hexahydroimidazo[1,2-alpha]pyridine. |
AID371215 | Insecticidal activity against imidacloprid-resistant Nilaparvata lugens | 2008 | Bioorganic & medicinal chemistry letters, Dec-15, Volume: 18, Issue:24 | cis-Nitromethylene neonicotinoids as new nicotinic family: synthesis, structural diversity, and insecticidal evaluation of hexahydroimidazo[1,2-alpha]pyridine. |
AID371214 | Insecticidal activity against imidacloprid-sensitive Nilaparvata lugens | 2008 | Bioorganic & medicinal chemistry letters, Dec-15, Volume: 18, Issue:24 | cis-Nitromethylene neonicotinoids as new nicotinic family: synthesis, structural diversity, and insecticidal evaluation of hexahydroimidazo[1,2-alpha]pyridine. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Research
Studies (17)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (5.88) | 29.6817 |
2010's | 15 (88.24) | 24.3611 |
2020's | 1 (5.88) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 13.14
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (13.14) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 17 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |